# FY20 PHASE I SBIR CONTRACT - TOPIC 401 - PHASE I SBIR CONTRACT QUANTITATIVE BIOMIMETIC MRI BREAST TISSUE AND TUMOR PHANTOM: TOWARD A COMPREHENSIVE PHA

> **NIH NIH N43** · CALIBERMRI, INC. · 2020 · $399,778

## Abstract

Research statistics have confirmed that breast cancer early detection saves lives. It is important 
that the patient is staged properly with the lowest possible side effects (morbidity). The best personalized treatment 
with almost immediate feedback on efficacy is critical to addressing the spread of breast cancer in 
a timely manner. Creation of a biomimetic quantitative MRI platform to guide the optimization of 
MRI scanners will enable and improve early breast cancer detection by providing a basis for 
quantitative assessment of tumor progression during treatment, and providing a means for cancer 
staging based on qMRI biomimics of primary tumor and lymph nodes. It is believed that this will 
drive research on using MRI to assess lymph nodal status and ultimately avoid many of the currently 
required lymph node biopsies and lymph node removal.

## Key facts

- **NIH application ID:** 10274011
- **Project number:** 75N91020C00056-0-9999-1
- **Recipient organization:** CALIBERMRI, INC.
- **Principal Investigator:** TODOR KARAULANOV
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $399,778
- **Award type:** —
- **Project period:** 2020-09-16 → 2021-06-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10274011

## Citation

> US National Institutes of Health, RePORTER application 10274011, FY20 PHASE I SBIR CONTRACT - TOPIC 401 - PHASE I SBIR CONTRACT QUANTITATIVE BIOMIMETIC MRI BREAST TISSUE AND TUMOR PHANTOM: TOWARD A COMPREHENSIVE PHA (75N91020C00056-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10274011. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*